NanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.
01 1NanoAlvand
02 1Strides Pharma Science
03 3Accord healthcare
04 1Accure Labs
05 2Bayer AG
06 2EBEWE Pharma Ges.m.b.H Nfg. KG
07 3EMD Serono
08 3Fresenius Kabi AB Brunna
09 1Fresenius Kabi Austria
10 3Fresenius Kabi USA
11 3Hikma Pharmaceuticals
12 3Hospira, Inc.
13 1Meda - Asker
14 1Meda Ab
15 1Meda Pharmaceuticals Inc.
16 3Meitheal Pharmaceuticals
17 1Merck Serono
18 1Naprod Life Sciences
19 3Rising Pharmaceuticals Inc
20 7Sandoz B2B
21 2Viatris
01 2Concentrate For Infusion Solution
02 5Concentrate For Solution For Infusion
03 3Concentrate to the infusion fluid
04 1INF
05 1INJECTABLE; INJECTION
06 21INJECTABLE;INJECTION
07 1INJECTION
08 1Liquid Injection
09 3Mitoxantrone 10Mg 5Ml 1 Units Parenteral Use
10 4Mitoxantrone 20Mg 10Ml 1 Units Parenteral Use
11 1SOLUTION
12 1Vial
13 2Blank
01 1Approved
02 1Cancelled
03 9DISCN
04 3Deregistered
05 2Generic
06 1Prescription
07 12RX
08 2Suspensed
09 15Blank
01 18MITOXANTRONE HYDROCHLORIDE
02 1MITOXANTRONE INJECTION
03 3Mitoxantron Ebewe
04 1Mitoxantron Sandoz
05 1Mitoxantrona Accord
06 4Mitoxantrone
07 1Mitoxantrone Mylan
08 1Mitoxantrone Strides
09 1Mitoxantrone-Hexal
10 2Mitozantrone Ebewe
11 4NOVANTRONE
12 4Novantrone
13 2Onkotrone
14 1Xantomit
15 2Blank
01 2Australia
02 1Canada
03 2India
04 1Iran
05 7Italy
06 3Norway
07 1South Africa
08 3Spain
09 4Sweden
10 22USA
NanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.
Regulatory Info :
Registration Country : Iran
Brand Name : Xantomit
Dosage Form : Vial
Dosage Strength : 20MG/10ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Iran
Synergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.
Regulatory Info : Deregistered
Registration Country : Sweden
Brand Name : Mitoxantrone Strides
Dosage Form : Concentrate For Solution For Infusion
Dosage Strength : 2mg/ml
Packaging :
Approval Date : 05/06/2013
Application Number : 20110513000016
Regulatory Info : Deregistered
Registration Country : Sweden
Regulatory Info : DISCN
Registration Country : USA
Brand Name : NOVANTRONE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : EQ 20MG BASE/10ML (EQ 2MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1987-12-23
Application Number : 19297
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : NOVANTRONE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : EQ 25MG BASE/12.5ML (EQ 2MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1987-12-23
Application Number : 19297
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : NOVANTRONE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : EQ 30MG BASE/15ML (EQ 2MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1987-12-23
Application Number : 19297
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : MITOXANTRONE HYDROCHLORIDE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : EQ 20MG BASE/10ML (EQ 2MG BASE/ML)
Packaging :
Approval Date : 2008-05-14
Application Number : 78606
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : MITOXANTRONE HYDROCHLORIDE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : EQ 25MG BASE/12.5ML (EQ 2MG BASE/ML)
Packaging :
Approval Date : 2008-05-14
Application Number : 78606
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : MITOXANTRONE HYDROCHLORIDE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : EQ 20MG BASE/10ML (EQ 2MG BASE/ML)
Packaging :
Approval Date : 2006-04-11
Application Number : 77496
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : MITOXANTRONE HYDROCHLORIDE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : EQ 25MG BASE/12.5ML (EQ 2MG BASE/ML)
Packaging :
Approval Date : 2006-04-11
Application Number : 77496
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : MITOXANTRONE HYDROCHLORIDE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : EQ 30MG BASE/15ML (EQ 2MG BASE/ML)
Packaging :
Approval Date : 2006-04-11
Application Number : 77496
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : MITOXANTRONE HYDROCHLORIDE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : EQ 20MG BASE/10ML (EQ 2MG BASE/ML)
Packaging :
Approval Date : 2006-04-11
Application Number : 76611
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : MITOXANTRONE HYDROCHLORIDE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : EQ 25MG BASE/12.5ML (EQ 2MG BASE/ML)
Packaging :
Approval Date : 2006-04-11
Application Number : 76611
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : MITOXANTRONE HYDROCHLORIDE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : EQ 30MG BASE/15ML (EQ 2MG BASE/ML)
Packaging :
Approval Date : 2006-04-11
Application Number : 76611
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : MITOXANTRONE HYDROCHLORIDE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : EQ 20MG BASE/10ML (EQ 2MG BASE/ML)
Packaging :
Approval Date : 2006-04-11
Application Number : 76871
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : MITOXANTRONE HYDROCHLORIDE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : EQ 25MG BASE/12.5ML (EQ 2MG BASE/ML)
Packaging :
Approval Date : 2006-04-11
Application Number : 76871
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : MITOXANTRONE HYDROCHLORIDE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : EQ 30MG BASE/15ML (EQ 2MG BASE/ML)
Packaging :
Approval Date : 2006-04-11
Application Number : 76871
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : MITOXANTRONE HYDROCHLORIDE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : EQ 20MG BASE/10ML (EQ 2MG BASE/ML)
Packaging :
Approval Date : 2006-04-11
Application Number : 77356
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : MITOXANTRONE HYDROCHLORIDE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : EQ 25MG BASE/12.5ML (EQ 2MG BASE/ML)
Packaging :
Approval Date : 2006-04-11
Application Number : 77356
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : MITOXANTRONE HYDROCHLORIDE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : EQ 30MG BASE/15ML (EQ 2MG BASE/ML)
Packaging :
Approval Date : 2006-04-11
Application Number : 77356
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : NOVANTRONE
Dosage Form : INJECTABLE; INJECTION
Dosage Strength : EQ 2MG BASE/ML
Packaging :
Approval Date :
Application Number : 21120
Regulatory Info :
Registration Country : USA
